Staging PET/CT better defines extent of mantle cell lymphomaSeptember 19, 2019Mantle Cell LymphomaB Cell Lymphoma
Rituximab, bendamustine look better than chemo alone in MCLSeptember 7, 2019Mantle Cell LymphomaB Cell Lymphoma
Ibrutinib-rituximab induction yields ‘unprecedented’ responses in MCLAugust 27, 2019Mantle Cell LymphomaB Cell Lymphoma
Obinutuzumab-lenalidomide combo shows promise in relapsed/refractory FLAugust 21, 2019Follicular LymphomaB Cell Lymphoma
Ibrutinib/rituximab effective, safe as frontline treatment for older patients with MCLAugust 12, 2019Mantle Cell LymphomaB Cell Lymphoma
Low-dose radiation therapy looks effective in hard-to-treat MCLAugust 7, 2019Mantle Cell LymphomaB Cell Lymphoma
FDA approves rituximab biosimilar for cancer, autoimmune disordersJuly 23, 2019B Cell LymphomaCLLFollicular Lymphoma
